10-Q: Nu Skin Enterprises Reports Mixed Q1 2024 Results Amidst Restructuring and Market Headwinds

Nu Skin Enterprises experienced a revenue decline in the first quarter of 2024, impacted by macroeconomic challenges and restructuring, though partially offset by growth in its Rhyz segment.

Summary

• Nu Skin Enterprises reported a 13.3% decrease in revenue for the first quarter of 2024, totaling $417.3 million, compared to $481.5 million in the same period last year.
• The company's core Nu Skin segments saw a 19.7% revenue decline, while the Rhyz segments experienced a 57.5% increase, driven by acquisitions and organic growth.
• Earnings per share decreased significantly to $(0.01) from $0.23 in the prior year, primarily due to the revenue decline.
• The company's customer base, paid affiliates, and sales leaders declined by 19%, 30%, and 12%, respectively, year-over-year.
• The company launched its new ageLOC WellSpa iO device, generating approximately $23.7 million in revenue.
• The company is planning to launch MYND360, a new brand focused on cognitive health.
• The company's gross profit margin was 70.5%, down from 72.3% in the prior year, impacted by the lower margin of the manufacturing segment.
• The company incurred $7.1 million in restructuring and impairment expenses.
• The company's interest expense increased to $7.3 million from $4.9 million due to increased borrowings.
• The company's effective tax rate was 148.4% compared to 22.0% in the prior year, impacted by lower profitability and stock award vesting.

Sentiment

Score: 4

Explanation: The document presents a mixed picture with significant revenue and profit declines, offset by some growth in the Rhyz segment and new product launches. The overall tone is cautious, reflecting the challenges the company is facing.

Positives

• The Rhyz segment showed strong growth with a 57.5% increase in revenue.
• The company successfully launched the ageLOC WellSpa iO device, generating $23.7 million in revenue.
• The company is planning to launch MYND360, a new brand focused on cognitive health.
• The company's manufacturing segment revenue increased by 40.6% due to new customers and automation efforts.
• The company generated $3.3 million in cash from operations, compared to a net outflow of $22.1 million during the prior-year period.

Negatives

• The company experienced a significant 13.3% decrease in overall revenue.
• The core Nu Skin segments saw a 19.7% revenue decline.
• Earnings per share decreased to $(0.01) from $0.23 in the prior year.
• The company's customer base, paid affiliates, and sales leaders all declined year-over-year.
• The company's gross profit margin decreased to 70.5% from 72.3% in the prior year.
• The company's effective tax rate was 148.4%, negatively impacted by lower profitability and stock award vesting.

Risks

• The company is facing macroeconomic challenges that are negatively impacting consumer spending and customer acquisition.
• The company is experiencing headwinds from its ongoing transformation process.
• The company's goodwill is considered at risk of future impairment due to the recent decline in the company's stock price and market capitalization.
• The company's revenue and profitability forecasts used in the goodwill impairment assessment assume a recovery from the recent downturn, which may not occur.
• The company is subject to government regulations and tax audits, which could result in additional liabilities.
• The company is experiencing delays in repatriating cash from Argentina.

Future Outlook

The company remains optimistic for the remainder of 2024, with plans to hold its Global Nu Skin Live! event and launch MYND360. The company anticipates continued growth in its Rhyz segment.

Management Comments

• The company's revenue in the first quarter of 2024 was negatively impacted 3.8% from foreign-currency fluctuations.
• The declines for the three-month period ended March 31, 2024 were largely driven by the continued macroeconomic challenges we’ve been facing in our markets, which have negatively impacted consumer spending and customer acquisition.
• While we continue to make progress on our long-term vision, we have experienced headwinds from the transformation process.
• We remain optimistic for the remainder of 2024 with our third quarter Global Nu Skin Live!, which for 2024 will be held in South Korea for our eastern markets and the United States for our western markets.
• Rhyz is a key component of our business, and we anticipate its continued growth in the coming years both on an absolute basis and as a percentage of our consolidated revenue.

Industry Context

The direct selling industry is facing challenges due to macroeconomic factors and changing consumer behavior. Nu Skin's performance reflects these broader trends, with the company attempting to diversify its revenue streams through acquisitions and new product launches.

Comparison to Industry Standards

• Nu Skin's revenue decline is worse than some of its competitors in the direct selling industry, which have shown more resilience in the face of economic headwinds.
• The company's Rhyz segment growth is a positive sign, as many direct selling companies are looking to diversify their revenue streams.
• The company's restructuring efforts are similar to those of other companies in the industry that are trying to optimize their operations and reduce costs.
• The company's launch of new products and devices is in line with industry trends, as companies are trying to innovate and attract new customers.
• The company's customer and affiliate declines are concerning, as these are key metrics for direct selling companies.

Management Changes

Related Party Transactions

• The company entered into a consulting agreement with Joseph Y. Chang, the former Chief Scientific Officer, effective March 30, 2024.

Stakeholder Impact

• Shareholders are negatively impacted by the decrease in revenue and earnings per share.
• Employees may be impacted by the ongoing restructuring efforts.
• Customers may be impacted by price increases and changes in product offerings.
• Sales leaders and affiliates are impacted by changes in compensation structures and eligibility requirements.

Next Steps

• The company plans to hold its Global Nu Skin Live! event in the third quarter of 2024.
• The company plans to launch MYND360, a new brand focused on cognitive health.
• The company expects to substantially complete its 2023 restructuring plan during the first half of 2024.
• The company will continue to evaluate its business, including its product portfolio, global processes and organization, and operational footprint.

Key Dates

Keywords

Nu Skin, Rhyz, Direct Selling, ageLOC, WellSpa iO, MYND360, Restructuring, Revenue Decline, Financial Results, Beauty, Wellness, Multi-level Marketing